N/A
Completed N=185
A Novel Transition Program to Reduce Disability After Stroke
Source: ClinicalTrials.gov NCT03485820 ↗Enrolled (actual)
185
Serious AEs
0.0%
Results posted
Mar 2025
Primary outcomePrimary: Reintegration to Normal Living Index (RNLI) — 60.8; 61.2; 74.8; 73.9 score on a scale — p=0.76
Summary
This study evaluates a program designed to help individuals transition home from inpatient rehabilitation following an ischemic or hemorrhagic stroke. Half of the participants will receive a stroke education program while the other half will receive an environmental modifications program.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Reintegration to Normal Living Index (RNLI) |
60.8; 61.2; 74.8; 73.9 | 0.76 |
| SECONDARY Stroke Impact Scale (SIS) - Activities of Daily Living (ADL) Domain |
55.3; 57.0; 66.4; 69.9 | 0.60 |
| SECONDARY In-Home Occupational Performance Evaluation (I-HOPE) - Activity Score |
0.73; 0.73; 0.77; 0.78 | 0.83 |
| SECONDARY In-Home Occupational Performance Evaluation (I-HOPE) - Performance Score |
2.42; 2.65; 3.60; 3.44 | 0.046 sig |
| SECONDARY In-Home Occupational Performance Evaluation (I-HOPE) - Satisfaction Score |
2.24; 2.53; 3.56; 3.33 | 0.02 sig |
| SECONDARY In-Home Occupational Performance Evaluation (I-HOPE) - Barrier Severity Score |
67.0; 64.4; 30.5; 38.4 | 0.07 |
Eligibility Criteria
Inclusion Criteria
- aged ≥50 years
- acute ischemic or hemorrhagic stroke diagnosis
- independent ADLs prior to stroke (premorbid Modified Rankin Scale Score ≤2)
- plan to discharge to home
Exclusion Criteria
- severe terminal systemic disease that limits life expectancy to < 6 months
- previous disorder (e.g. dementia) that makes interpretation of the self-rated scales difficult or Short Blessed Test (SBT) score of 10 or less (indicating significant cognitive impairment)
- moderate to severe Aphasia as determined by the NIHSS Best Language rating of 2 or more
- reside in congregate living facility.
Data sourced from ClinicalTrials.gov (NCT03485820). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.